行情

CDNA

CDNA

CareDx
NASDAQ

实时行情|Nasdaq Last Sale

19.73
+0.47
+2.44%
盘后: 19.77 +0.04 +0.20% 16:11 11/15 EST
开盘
19.46
昨收
19.26
最高
20.23
最低
19.46
成交量
44.52万
成交额
--
52周最高
41.27
52周最低
19.11
市值
8.37亿
市盈率(TTM)
-39.1857
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CDNA 新闻

  • 屡破新高美股向上空间或打开 美联储将成为拦路虎?
  • 第一财经.1小时前
  • 消息人士:沙特阿美将不会在美国上市
  • 新浪美股.1小时前
  • 美国零售业遇“寒冬”,TJX为何能独领风骚?
  • 新浪财经-自媒体综合.2小时前
  • 第三季度营收大增28.7%,京东的加速度与下沉路
  • 海外网.3小时前

更多

所属板块

生物技术和医学研究
+1.25%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

CDNA 简况

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.
展开

Webull提供CareDx Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。